Brent Saunders
Brent is a globally recognized CEO, executive chairperson and philanthropist who is dedicated to transforming industries and solving unmet medical needs.
About Brent
Brent is a health care executive and entrepreneur with more than 25 years of experience leading businesses across biopharma, eye care, medical aesthetics and health care technology. His experience includes central nervous system disorders, gastrointestinal diseases, women’s health, dermatology and eye care. His career has focused on bringing new medicines and technologies to patients, improving operating performance and building teams that can deliver sustained growth. During his time as CEO, the companies he led received at least 20 FDA approvals for medicines, new formulations and medical devices.
Career
Brent previously served as chairman, president and CEO of Allergan, where he led a global portfolio of medicines and medical aesthetics products. During his tenure, the company advanced its research and development pipeline and brought new treatments to market across areas including eye care, neuroscience, women’s health and dermatology. He also served twice as CEO of Bausch + Lomb, most recently from 2023 to 2026, where he focused on strengthening the company’s operations, accelerating innovation and driving growth across its eye care businesses.
Giving Back
Brent has long sought to make health care more accessible to those in need, with a focus on mental health services.
Recognition
Brent has been widely recognized by various organizations for his contributions to charitable initiatives, entrepreneurial achievements and industry leadership.
News & Insights
Find coverage and updates on media appearances, speaking engagements, thought leadership and more.
Bausch + Lomb CEO: the AI hysteria is nothing new
The AI arms race will be won by the companies whose people keep learning what to do with it, Brent writes for Fortune.
The Real Difference in the AI Era
Brent shares his perspective on AI leadership and organizational culture with Alan Murray for the Wall Street Journal CEO Brief.